Authors



Steve Martinson

Latest:

The Tao of Tau: Developing the “My Vancomycin Calculator” App

Creating a free app to assist in vancomycin dosing proved to be an entertaining and enlightening journey.




Nick Crozier, PharmD, MBA, BCPS, BCOP

Latest:

Driving Clinical Pharmacy Development With Data-Driven Metrics and Insights

There are no clearly defined, widely accepted clinical pharmacist metrics.


Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA

Latest:

A Season of Growth: Reflecting on Summer, Connection, and the Power of Mentorship

August marks a pivotal time for oncology pharmacy, blending transitions, celebrations, and new beginnings as professionals prepare for the upcoming season.


Christy Cheung, PharmD

Latest:

Artificial Intelligence Applications in Education and Pharmacy Practice

By interpreting and applying the data provided by algorithms, pharmacists are uniquely equipped to guide development of more patient-centered care.


Celeste Chung, PharmD

Latest:

An Overview of Vitamins and Supplements in Multiple Sclerosis

By examining the evidence, pharmacists can gain insights into whether these supplements could be integrated into MS treatment regimens to improve patient outcomes.


Brigid Hurst, PharmD

Latest:

Does Corticosteroid Use Have a Role in Severe Community-Acquired Pneumonia?

Since the most recent guidelines were published, more evidence has emerged regarding intravenous corticosteroids for severely ill patients.


Steven Pipe, MD

Latest:

Expert: Pharmacists Play Key Role in Counseling, Managing Expectations for Etranacogene Dezaparvovec

Pharmacists are integral to setting patient expectations, monitoring liver health, and ensuring adherence to long-term follow-up for optimal outcomes with etranacogene dezaparvovec.


Amit Patel, MD

Latest:

Pharmacy-Led Enhanced Patient Education in the Emergency Department

In this retrospective study, investigators evaluated a pharmacy-led initiative in the emergency department (ED), finding a potential reduction in ED revisits and hospital readmissions, though results were not statistically significant.


Rachel Chandra, PharmD, MPH, FASHP

Latest:

Understanding Gender-Affirmative Care Beyond Women’s Health

Gender-affirming care and inclusive practices are essential for health equity.


Hannah Ayers

Latest:

Case Studies: May 2022

How would you handle these patients' questions?


Gary Hopkins

Latest:

Medically Integrated Health System Specialty Pharmacies Deliver Strong Outcomes

These facilities provide significant value to payers and patients.


Jerry Rebo, PharmD, BCPS, BCCCP, DPLA

Latest:

Sugammadex: Use Criteria Optimization and Outcomes Data Evaluation

Establishing new use criteria led to an 86% reduction in the utilization of sugammadex with no appreciable impact on measured outcomes.


Abdulwhab Shremo Msdi, PharmD, BCIDP

Latest:

From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy Research

Abdulwhab Shremo Msdi, PharmD, BCIDP, advances research in infectious diseases and microbiome-related conditions.


Enriqueta Felip, MD, PhD

Latest:

Subcutaneous Pembrolizumab Matches IV in Lung Cancer Trial

Enriqueta Felip, MD, PhD, discussed the benefits of subcutaneous pembrolizumab for patients with metastatic non–small cell lung cancer.



Zachery Halford, PharmD, BCOP, BCPPS

Latest:

Immune Checkpoint Inhibitor-Associated Nephritis: A Case of Nivolumab-Induced Acute Kidney Injury in a Patient with Urothelial Carcinoma

This case highlights the importance of recognizing ICPI-AKI, implementing effective therapeutic interventions, and understanding the clinical context to prevent irreversible renal damage.


Holly Wieneke, RPh

Latest:

Evolving Business Models in Specialty and Infusion Pharmacy

Hospitals and health systems are adapting specialty and infusion pharmacy strategies to meet evolving payer mandates, rising costs, and shifting care models by expanding biosimilar use, optimizing prior authorizations, and integrating technology to enhance patient access and operational efficiency.


Shashank R. Cingam, MD

Latest:

Current Treatment Approaches for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Relapsed treatment has evolved with CAR T, bispecific antibodies, and immunotherapies.


Veronica Sozio, PharmD, BCPS

Latest:

Going with the Flow: Updates in Diabetes and Chronic Kidney Disease

CKD is a complication of diabetes. Emerging treatments aim to optimize management and reduce risks. Pharmacists are key in applying new evidence to clinical practice.


Margaret T Peinovich, PharmD, BCPS

Latest:

Evaluation of a Chemotherapy Advanced Preparation Pilot Program to Improve Throughput in an Oncology Infusion Clinic

Pharmacy workflow changes in the preparation of chemotherapy products can reduce patient chair time.


Ashley L. Weaver, PharmD Candidate

Latest:

Understand the Emergency Management Assistance Comp

This interstate agreement can empower pharmacists to respond to large-scale emergencies


Kaitlin Beyler, PharmD Candidate 2023

Latest:

For the First Time Ever, CDC Makes Specific Recommendations on Flu Vaccines for Geriatric Patients

CDC makes groundbreaking shift by providing influenza vaccination recommendations for the geriatric population.


Rachel Massey, PharmD Candidate

Latest:

What You Should Know About Norgestrel, An OTC Birth Control Option

Knowing the benefits and effects of norgestrel can assist pharmacists when counseling patients.


Robin R. Vidal, PharmD

Latest:

The Role of Pharmacists and Prescription Monitoring Programs in Stemming the Opioid Epidemic

Pharmacists can be instrumental in reducing the main challenges in opioid use disorder—namely supply, demand, and harm.


Tiffany Capps, CPhT

Latest:

Career Pathways Play Key Part in Retention

Redefining technician roles boosts workflow efficiencies, strengthens pharmacies' bottom lines.


Michael A. Maccia, PharmD, BCCCP

Latest:

The Impact of Pharmacist-Managed Insulin Therapy in the Intensive Care Unit

Critically ill patients treated with a pharmacist-managed insulin protocol achieved higher rates of glucose control than those treated with conventional methods.


Michele Riccardi, PharmD, BCPS

Latest:

Patient Case Study: Use of Dietary Supplements in Patients With Breast Cancer

Even when safe, oral supplement use may not be appropriate to use during cancer treatment or recovery.

© 2025 MJH Life Sciences

All rights reserved.